The efficacy of oral doxycycline was compared with that of IV ceftriaxone (Rocephin) in a randomized trial of 118 patients with Lyme neuroborreliosis (Lancet Neurol. 2008;7:690-695). Patients were ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Amid growing ...

(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release, ADPH said it is ...

September 11, 2007 — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated with concomitant use of ...

Please provide your email address to receive an email when new articles are posted on . A trial that evaluated three alternative treatments for anogenital gonorrhea found that a single dose of ...

SCHAUMBURG, Ill., July 16 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, today announced that it haslaunched both ceftriaxone for injection, USP, and cefuroxime for ...

BEDFORD, Ohio, July 16 Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., announced FDA approval to begin shipping Ceftriaxone for Injection USP. This product is AP rated and is ...

Sequential high-dose chemotherapy with autologous stem cell rescue for children with high-risk medulloblastoma and supratentorial primitive neuroectodermal tumours ...

The FDA has notified healthcare professionals of an update to a previous alert from September 2007 addressing the interaction of ceftriaxone with calcium-containing products. At the FDA’s request, ...

July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...